Search results
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
AOL· 4 days agoRinvoq helped 19.9% of patients simultaneously achieve near-complete skin clearance with a no-to-little itch after 16 weeks of treatment, compared with 8.9% of patients treated with Dupixent ...
Jim Cramer's quick thoughts on 5 stocks: Chevron, Snap, Intel, AbbVie and Colgate
CNBC· 3 days agoChevron : The oil giant beat on quarterly earnings but missed on revenue. "Maybe this is a chance to...
REFILE-AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study
Reuters via Yahoo Finance· 4 days ago(Corrects to remove extraneous text and to add Regeneron ticker symbol) April 25 (Reuters) - AbbVie said on Thursday its drug, Rinvoq, for treating a type of inflammatory ...
AbbVie Shares Close Down 4.6%, Sees Additional Humira Volume Erosion in 2Q
Morningstar· 3 days agoShares of AbbVie lost 4.6% to close at $159.62 on Friday after the company warned about the effects of losing the exclusivity of its patent for the arthritis medication Humira ...
ZERO Prostate Cancer Run/Walk in Kenosha on May 19
Kenosha News· 1 hour agoZERO Prostate Cancer, will hold a Kenosha ZERO Prostate Cancer Run/Walk on Sunday, May 19, at HarborPark.
AbbVie Reports First-Quarter 2024 Financial Results
Hometownsource.com· 3 days agoReports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 6 days agoEntyvio sales were 227.6 billion yen in the third quarter of fiscal year 2023, an increase of 14% quarter over quarter due to the launch of its...
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Reuters· 4 days agoCigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no...
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Reuters via Yahoo Finance· 4 days agoCigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 5 days agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
